BioNTech SEEigentümerstruktur
| Preis (2026-07-24) | 52W Hoch | 52W Tief |
| 89.33 USD | 124 USD | 79,52 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 121,576 USD | 13 | 3 | 5 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 252.884.261 | 3,32 | 2,73 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name BioNTech SE
Mitarbeiter 7.807
Handelsplatz NASDAQ
Ticker Symbol BNTX
IPO Datum 2019-10-10
Adresse An der Goldgrube 12, Mainz, Germany, 55131
Webseite https://www.biontech.de
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Ugur Sahin M.D. | Co-Founder, CEO & Chair of the Management Board |
| 2 | Dr. Ozlem Tureci M.D. | Co-Founder, Chief Medical Officer & Member of Management Board |
| 3 | Mr. Ramon Zapata-Gomez | CFO & Member of Management Board |
| 4 | Dr. Sierk Pötting Ph.D. | MD, COO & Member of Management Board |
| 5 | Dr. James Timothy Patrick Ryan Ph.D. | Chief Legal & Business Officer and Member of the Management Board |
| 6 | Ms. Annemarie Hanekamp | Chief Commercial Officer & Member of Management Board |
| 7 | Ms. Kylie Jimenez | Chief People Officer & Member of Management Board |
| 8 | Ms. Lisa Birringer | Senior Vice President of Global Financial Reporting & Accounting |
| 9 | Mr. Douglas Maffei Ph.D. | Vice President of Strategy & Investor Relations |
| 10 | Jasmina Alatovic | Vice President Corporate Communications |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | T. Rowe Price Investment Management,Inc. | 0,00% | 0,00 Mio. USD |
| 2 | FMR Inc | 0,00% | 0,00 Mio. USD |
| 3 | PRIMECAP Management Company | 0,00% | 0,00 Mio. USD |
| 4 | Flossbach von Storch AG | 0,00% | 0,00 Mio. USD |
| 5 | Dodge & Cox | 0,00% | 0,00 Mio. USD |
| 6 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 7 | BNP Paribas Arbitrage, SA | 0,00% | 0,00 Mio. USD |
| 8 | Temasek Holdings Ltd. | 0,00% | 0,00 Mio. USD |
| 9 | Citadel Advisors Llc | 0,00% | 0,00 Mio. USD |
| 10 | Bank of America Corp | 0,00% | 0,00 Mio. USD |
| 11 | GSK PLC | 0,00% | 0,00 Mio. USD |
| 12 | Baillie Gifford & Co Limited. | 0,00% | 0,00 Mio. USD |
| 13 | First Trust Advisors L.P. | 0,00% | 0,00 Mio. USD |
| 14 | UBS Asset Mgmt Americas Inc | 0,00% | 0,00 Mio. USD |
| 15 | Massachusetts Financial Services Company | 0,00% | 0,00 Mio. USD |
| 16 | Long Focus Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 17 | Candriam Luxembourg S.C.A. | 0,00% | 0,00 Mio. USD |
| 18 | Morgan Stanley - Brokerage Accounts | 0,00% | 0,00 Mio. USD |
| 19 | DekaBank Deutsche Girozentrale | 0,00% | 0,00 Mio. USD |
| 20 | Victory Capital Management Inc. | 0,00% | 0,00 Mio. USD |